Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the talks
-
1. Streptococcus pneumoniae: serotype diversity and epidemiology
- Dr. Bambos Charalambous
-
2. Tuberculosis: new treatments in evolution
- Prof. Stephen Gillespie
-
3. Current drugs for TB treatment
- Dr. Kasha Singh
-
4. Global progress in TB vaccine development
- Prof. Helen McShane
-
5. Management of MDR and XDR TB
- Prof. Martin Boeree
-
6. Non-tuberculous mycobacterial pulmonary disease (NTM-PD)
- Prof. Jakko van Ingen
-
7. The making of an influenza pandemic
- Prof. Jonathan Van-Tam
-
8. Responding to pandemic influenza
- Prof. Jonathan Van-Tam
- Dr. Chloe Sellwood
-
9. Controlling pandemic flu
- Prof. John Oxford
-
10. The future of influenza vaccines
- Dr. Marc P. Girard
-
11. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
- Dr. Marietjie Venter
- Mrs. Orienka Hellferscee
-
12. RSV vaccine development
- Prof. Ruth Karron
-
13. Respiratory mycoplasmas
- Prof. Stephen Gillespie
-
14. Infection in the cystic fibrosis lung
- Dr. Stuart Elborn
-
15. The role of infection at COPD exacerbations
- Prof. Wisia Wedzicha
-
16. An overview of non-cystic fibrosis bronchiectasis
- Dr. Maeve P. Smith
-
18. Pathogen discovery in the respiratory tract
- Dr. H. Rogier van Doorn
-
19. Aspergillosis infections and the lung
- Prof. Rosemary Barnes
-
20. Parasitic lung infections: protozoa, cestodes & trematodes
- Dr. Vannan Kandi Vijayan
-
21. Parasitic lung infections: nematodes
- Dr. Vannan Kandi Vijayan
-
22. Improving respiratory diagnostics (viruses)
- Prof. David Murdoch
Printable Handouts
Navigable Slide Index
- Introduction
- Aims of talk
- Bronchiectasis (1)
- Pathophysiology
- Bronchiectasis (2)
- Mucociliary clearance mechanism
- Chronic airways infection (1)
- Chronic airways infection (2)
- Chronic airways inflammation
- Chronic colonisation and inflammation
- Vicious cycle of inflammation and infection
- Aetiology (1)
- Aetiology (2)
- Aetiology: incidence rates
- Prevalence and burden
- Bronchiectasis: prevalence and burden
- Clinical features
- Symptoms and signs
- Diagnosis
- Diagnosis: methods and defining features
- Characteristics by disease severity
- Management
- Management of chronic bronchiectasis
- Goals of management
- A multi-faceted approach to management
- Patient education (1)
- Patient education (2)
- Airway clearance
- Airway clearance: techniques
- Chest physiotherapy: aims
- Chest physiotherapy: results
- Chest physiotherapy: techniques
- Physiotherapy techniques in clinical trials
- Pulmonary rehabilitation: clinical trials
- Pulmonary rehabilitation: results
- Nebulised saline and beta-2 agonists
- Nebulised saline
- rhDNase: clinical trials & results
- Mannitol: clinical trials & results
- Inhaled corticosteroids: clinical trials
- Inhaled corticosteroids: results
- Airway clearance: recommendations in practice
- Long term strategies: anti-inflammatories
- Anti-inflammatories
- Long term strategies: antimicrobials
- Long term antibiotics: aims and techniques
- Long term oral antibiotics: clinical trials
- Long term nebulised antibiotics- clinical trials (1)
- Long term nebulised antibiotics- clinical trials (2)
- Long term oral antibiotics: recommendations
- Long term nebulised antibiotics: recommendations
- Long term strategies: eradication of organisms
- Eradication of organisms
- Long term strategies: surgery
- Surgery
- Management: summary
- Future
Topics Covered
- Non-cystic fibrosis bronchiectasis
- A vicious cycle of chronic airways infection and inflammation
- Significant clinical and socioeconomic morbidity
- Crucial to try to establish and treat any underlying aetiology
- Disease severity should be assessed
- Long term management is multifaceted and includes airway clearance techniques, anti-inflammatory strategies and antimicrobial strategies
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Smith, M.P. (2013, July 11). An overview of non-cystic fibrosis bronchiectasis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 31, 2024, from https://doi.org/10.69645/PDRJ8559.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Maeve P. Smith has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.